论文部分内容阅读
以脑血栓和脑动脉硬化病人86例及家兔等观察复方路通(复方羟乙基芦丁)片的实验性抗血栓作用,发现此药能抑制实验性血栓形成,降低血液粘度、血球压积及纤维蛋白原含量,缩短红细胞和血小板电泳时间,抑制ADP诱导的血小板聚集和增强纤维蛋白溶解活性,以及增加血流量。认为这些就是此药治疗梗塞性脑血管病的机理。
Experimental cerebral thrombosis and cerebral arteriosclerosis in 86 patients and rabbits observed compound Fanglu Tong (compound hydroxyethyl rutin) tablets antithrombotic effect and found that the drug can inhibit experimental thrombosis, reduce blood viscosity, hematocrit Product and fibrinogen content, shorten the red blood cells and platelet electrophoresis time, inhibit ADP-induced platelet aggregation and enhance fibrinolytic activity, and increase blood flow. Think that these are the mechanism that this medicine treats infarction cerebrovascular disease.